delta T cell proliferation, phenotype, TCR repertoire and function to PB gamma delta T cells when culturing cells with the NBP, Zometa (zoledronic acid), and IL-2. Fourteen days in culture resulted in significant fold increase in the proliferation of gamma delta T cells and in the percent of lymphocytes in both sample types. PB gamma delta T cells proliferated more robustly than CB with a 288.60 versus 21.32 fold increase, respectively. Additionally, in freshly isolated samples, CB gamma delta T cells comprised an average of 1.404% of the lymphocyte population, which was similar to PB gamma delta T cells, with an average of 2.319%. However, by day 14, PB gamma delta T cells increased to 70.15% of lymphocytes whereas CB gamma delta T cells increased to 12.49%. Phenotypically, we also examined TCRg9 and TCRd2 expression and found that the TCRg9d2 was a common clone in freshly isolated PB gamma delta T cells, which predominated after 14 days in culture. However, while the TCRg9d2 variant was present in CB gamma delta T cells, it was low before and after culture, suggesting that Zometa may not stimulate gamma delta T cells in CB the same as PB. The memory subsets of freshly isolated gamma delta T cells were similar for CB and PB. Yet following culture, PB gamma delta T cells were mostly CD45RO+ memory cells, specifically effector or central memory subsets, with significantly fewer CD45RA+ naïve cells, whereas more CB gamma delta T cells were of the intermediate CD45RA+CD45RO+ naïve subset. In addition, we also observed that memory status corresponded with the TCR variant; more Vg9 and Vd2 cells were memory cells and Vd1 cells were mostly naïve. Functionally, PB and CB gamma delta T cells had distinct cytokine secretion profiles both before and after culture. PB gamma delta T cells secreted more IFNg and TNFa after culture, while CB gamma delta T cells secreted more IL-10 and RANTES. As limited TCRgd phenotypic reagents are available, we developed a single cell PCR assay for genotypic analysis of the TCRgd repertoire. PCR analysis suggests that the TCRgd repertoire of freshly isolated cells is diverse in both samples types, with more variation among the CB gamma delta T cells, while TCRg9d2 is most prevalent in PB. Further analysis of the variant subsets is warranted and may give insight into how each of these receptor pairings affects gamma delta T cell function.
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